Professor, Internal Medicine, University of Michigan Medical School
Internal Medicine
Dr. A M. Fendrick, MD
|
|
Give Review
A M. Fendrick, MD practices Internal Medicine. He studied medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Fendrick is a published doctor as well. He has 99 publications published. The latest was: Value-Based Insurance Design: Aligning Incentives to Improve Cardiovascular Care.
Publications
- Value-Based Insurance Design: Aligning Incentives to Improve Cardiovascular Care.
- Price elasticity and medication use: cost sharing across multiple clinical conditions.
- Innovation of novel antibiotics: an economic perspective.
- Beyond usual care: The economic consequences of expanding treatment options in early pregnancy loss.
- Women's Health and the Affordable Care Act: High Hopes Versus Harsh Realities?
- Stroke Risk After Non-Stroke ED Dizziness Presentations: A Population-Based Cohort Study.
- The economics of resistant pathogens and antibiotic innovation.
- The Impact of Out-of-Pocket Costs on the Use of Intrauterine Contraception Among Women With Employer-sponsored Insurance.
- Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers.
- Cost of contraceptive methods to privately insured women in the United States.
- The effect of medical malpractice liability on rate of referrals received by specialist physicians.
- Comparative effectiveness research and formulary placement: the case of diabetes.
- Inside out: reversing the focus on emergency departments to enhance efficiency.
- Use of BPPV Processes in Emergency Department Dizziness Presentations: A Population-Based Study.
- Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention.
- Treatment of early pregnancy failure: does induced abortion training affect later practices?
- Cost-utility of aspirin and proton pump inhibitors for primary prevention.
- Value-based insurance design for diabetes mellitus: approaches to optimal pharmacoeconomic implementation.
- Value of computed tomography scans in ED dizziness visits: analysis from a nationally representative sample.
- Applying value-based insurance design to low-value health services.
- A pharmacoeconomic perspective on stroke prevention in atrial fibrillation.
- Value-based insurance design: implications for gastroenterology.
- Provider knowledge, attitudes, and treatment preferences for early pregnancy failure.
- Evidence that value-based insurance can be effective.
- Trends in patient cost sharing for clinical services used as quality indicators.
- Value-based insurance design: embracing value over cost alone.
- Healthcare utilization in community-acquired pneumonia episodes of care: a comparison across the continuum of managed care.
- Value based insurance design: maintaining a focus on health in an era of cost containment.
- Treatment patterns for early pregnancy failure in Michigan.
- Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention.
- Dizziness presentations in U.S. emergency departments, 1995-2004.
- Effects of increased patient cost sharing on socioeconomic disparities in health care.
- Impact of fixed-dose combination drugs on adherence to prescription medications.
- Confronting hysteria: a reply to Fairman and Curtiss.
- Value and increased cost sharing in the American health care system.
- Impact of decreasing copayments on medication adherence within a disease management environment.
- "Fiscally responsible, clinically sensitive" cost sharing: contain costs while preserving quality.
- Value-based insurance design: a "clinically sensitive, fiscally responsible" approach to mitigate the adverse clinical effects of high-deductible consumer-di...
- Defining cause of death in stroke patients: The Brain Attack Surveillance in Corpus Christi Project.
- Value-based insurance design.
- Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment.
- Implantable or external defibrillators for individuals at increased risk of cardiac arrest: where cost-effectiveness hits fiscal reality.
- Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists: the tortoise and the hare revisited.
- The future of health economic modeling: have we gone too far or not far enough?
- Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia.
- Rising out-of-pocket costs in disease management programs.
- Value-based insurance design: a "clinically sensitive" approach to preserve quality of care and contain costs.
- Meeting the challenge of colorectal cancer screening.
- Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
- Automated external defibrillator deployment in high schools and senior centers.
- Univariate solutions in a multivariate world: can we afford to practice as in the "good old days"?
- The effects of a professionally produced videotape on education and anxiety/distress levels for patients with newly diagnosed melanoma: a randomized, prospective clini...
- Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.
- Primary-care physicians' perceptions and practices on the management of GERD: results of a national survey.
- How to test for Helicobacter pylori in 2005.
- Value added radiology: using existing radiology services to improve cancer screening.
- Associations in breast and colon cancer screening behavior in women.
- PPI use in the OTC era: who to treat, with what, and for how long?
- Cost-effectiveness of in-home automated external defibrillators for individuals at increased risk of sudden cardiac death.
- Behavioral associations between prostate and colon cancer screening.
- COX-2 inhibitor use after Vioxx: careful balance or end of the rope?
- Cost-minimization analysis of once-weekly versus thrice-weekly epoetin alfa for chemotherapy-related anemia.
- Barriers to constraining health care cost growth.
- Acute exacerbation of chronic bronchitis: a primary care consensus guideline.
- Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
- Taking stock at 2 years--continuing the journey.
- Informed Choices in Anti-Inflammatory Drug Therapy: Why Patient Risk Matters.
- Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact?
- The health effects of restricting prescription medication use because of cost.
- Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.
- Extent and cost of informal caregiving for older Americans with symptoms of depression.
- Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.
- New and dis-improved: on the evaluation and use of less effective, less expensive medical interventions.
- Out-of-pocket health care expenditures among older Americans with dementia.
- Predicting nursing home admission: estimates from a 7-year follow-up of a nationally representative sample of older Americans.
- Improving cancer screening adherence: using the "teachable moment" as a delivery setting for educational interventions.
- Out-of-pocket health-care expenditures among older Americans with cancer.
- Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn.
- Incorporating patient-centered outcomes in the analysis of cost-effectiveness: imaging strategies for renovascular hypertension.
- Mechanisms to improve pharmaceutical use in managed care: to study controls, control the studies.
- Cost-effectiveness of automated external defibrillator deployment in selected public locations.
- Differences in the reporting of care-related patient injuries to existing reporting systems.
- Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
- What is the price of life and why doesn't it increase at the rate of inflation?
- The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect.
- The impact of including passive benefits in cost-effectiveness analysis: the case of automated external defibrillators on commercial aircraft.
- Approval times for new drugs: does the source of funding for FDA staff matter?
- Making cost-effectiveness analyses clinically relevant: the effect of provider expertise and biliary disease prevalence on the economic comparison of alternative diagn...
- Percutaneous stenting of incidental unilateral renal artery stenosis: decision analysis of costs and benefits.
- Viral respiratory infections due to rhinoviruses: current knowledge, new developments.
- Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis.
- Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
- Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis.
- The economic burden of non-influenza-related viral respiratory tract infection in the United States.
- Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
- Informal caregiving for chronic lung disease among older Americans.
- Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States.
- Cost-effective use of NSAIDs: issues pertinent to coxib use in managed care.
Schools
Harvard Medical School
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
Harvard Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1013006238 | |
| NPPES Provider LastName | FENDRICK | |
| NPPES Provider FirstName | A | |
| NPPES Provider ZIPCode | 481095352 | |
| NPPES Provider State | MI | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 50.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1013006238 |
| Last Name Of The Provider | FENDRICK |
| First Name Of The Provider | A |
| View All |
Similar Doctors
|
|
Dr. Martha L. Gray, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cheryl V. Gray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna Kalman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jenny N. Hsu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paula G. Davey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew A. Pappas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher A. Smith, MD |
|
|
Dr. Nabil Alkhoury Fallouh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leonel F. Hernandez Aya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas P. O'Connor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore J. Iwashyna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer K. Rai, MD
This Doctor is OpenDoctor Recommended.
|